DNA
Ginkgo Bioworks Holdings, Inc.
NYSE · Healthcare · Biotechnology · US
$11.65
+8.27%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 8.41x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.87x
- Price / sales
- 7.01x
- Price / cash flow
- -4.61x
Enterprise value
- Enterprise value
- $886.5M
- EV / sales
- 7.92x
- EV / EBITDA
- -3.66x
- EV / EBIT
- -3.05x
- Market cap
- $784.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026